462 related articles for article (PubMed ID: 9861036)
1. A decrease of reelin expression as a putative vulnerability factor in schizophrenia.
Impagnatiello F; Guidotti AR; Pesold C; Dwivedi Y; Caruncho H; Pisu MG; Uzunov DP; Smalheiser NR; Davis JM; Pandey GN; Pappas GD; Tueting P; Sharma RP; Costa E
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15718-23. PubMed ID: 9861036
[TBL] [Abstract][Full Text] [Related]
2. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study.
Guidotti A; Auta J; Davis JM; Di-Giorgi-Gerevini V; Dwivedi Y; Grayson DR; Impagnatiello F; Pandey G; Pesold C; Sharma R; Uzunov D; Costa E
Arch Gen Psychiatry; 2000 Nov; 57(11):1061-9. PubMed ID: 11074872
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Reelin signaling and neurodevelopmental trajectory in primary cultured cortical neurons with RELN deletion identified in schizophrenia.
Tsuneura Y; Sawahata M; Itoh N; Miyajima R; Mori D; Kohno T; Hattori M; Sobue A; Nagai T; Mizoguchi H; Nabeshima T; Ozaki N; Yamada K
Neurochem Int; 2021 Mar; 144():104954. PubMed ID: 33388358
[TBL] [Abstract][Full Text] [Related]
4. Disabled-1 acts downstream of Reelin in a signaling pathway that controls laminar organization in the mammalian brain.
Rice DS; Sheldon M; D'Arcangelo G; Nakajima K; Goldowitz D; Curran T
Development; 1998 Sep; 125(18):3719-29. PubMed ID: 9716537
[TBL] [Abstract][Full Text] [Related]
5. Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia.
Dong E; Agis-Balboa RC; Simonini MV; Grayson DR; Costa E; Guidotti A
Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12578-83. PubMed ID: 16113080
[TBL] [Abstract][Full Text] [Related]
6. Dendritic spine hypoplasticity and downregulation of reelin and GABAergic tone in schizophrenia vulnerability.
Costa E; Davis J; Grayson DR; Guidotti A; Pappas GD; Pesold C
Neurobiol Dis; 2001 Oct; 8(5):723-42. PubMed ID: 11592844
[TBL] [Abstract][Full Text] [Related]
7. Cortical bitufted, horizontal, and Martinotti cells preferentially express and secrete reelin into perineuronal nets, nonsynaptically modulating gene expression.
Pesold C; Liu WS; Guidotti A; Costa E; Caruncho HJ
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):3217-22. PubMed ID: 10077664
[TBL] [Abstract][Full Text] [Related]
8. Schizophrenia risk candidate EGR3 is a novel transcriptional regulator of RELN and regulates neurite outgrowth via the Reelin signal pathway in vitro.
Nie F; Zhang Q; Ma J; Wang P; Gu R; Han J; Zhang R
J Neurochem; 2021 Jun; 157(6):1745-1758. PubMed ID: 33113163
[TBL] [Abstract][Full Text] [Related]
9. Histological study in the brain of the reelin/Dab1-compound mutant mouse.
Yamamoto T; Setsu T; Okuyama-Yamamoto A; Terashima T
Anat Sci Int; 2009 Sep; 84(3):200-9. PubMed ID: 19221860
[TBL] [Abstract][Full Text] [Related]
10. DNA methyltransferase 1 regulates reelin mRNA expression in mouse primary cortical cultures.
Noh JS; Sharma RP; Veldic M; Salvacion AA; Jia X; Chen Y; Costa E; Guidotti A; Grayson DR
Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1749-54. PubMed ID: 15671176
[TBL] [Abstract][Full Text] [Related]
11. Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report.
Abdolmaleky HM; Cheng KH; Russo A; Smith CL; Faraone SV; Wilcox M; Shafa R; Glatt SJ; Nguyen G; Ponte JF; Thiagalingam S; Tsuang MT
Am J Med Genet B Neuropsychiatr Genet; 2005 Apr; 134B(1):60-6. PubMed ID: 15717292
[TBL] [Abstract][Full Text] [Related]
12. Reelin and disabled-1 expression in developing and mature human cortical neurons.
Deguchi K; Inoue K; Avila WE; Lopez-Terrada D; Antalffy BA; Quattrocchi CC; Sheldon M; Mikoshiba K; D'Arcangelo G; Armstrong DL
J Neuropathol Exp Neurol; 2003 Jun; 62(6):676-84. PubMed ID: 12834112
[TBL] [Abstract][Full Text] [Related]
13. Reelin is preferentially expressed in neurons synthesizing gamma-aminobutyric acid in cortex and hippocampus of adult rats.
Pesold C; Impagnatiello F; Pisu MG; Uzunov DP; Costa E; Guidotti A; Caruncho HJ
Proc Natl Acad Sci U S A; 1998 Mar; 95(6):3221-6. PubMed ID: 9501244
[TBL] [Abstract][Full Text] [Related]
14. Generation and analysis of novel Reln-deleted mouse model corresponding to exonic Reln deletion in schizophrenia.
Sawahata M; Mori D; Arioka Y; Kubo H; Kushima I; Kitagawa K; Sobue A; Shishido E; Sekiguchi M; Kodama A; Ikeda R; Aleksic B; Kimura H; Ishizuka K; Nagai T; Kaibuchi K; Nabeshima T; Yamada K; Ozaki N
Psychiatry Clin Neurosci; 2020 May; 74(5):318-327. PubMed ID: 32065683
[TBL] [Abstract][Full Text] [Related]
15. DNA-methyltransferase 1 mRNA is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains.
Veldic M; Caruncho HJ; Liu WS; Davis J; Satta R; Grayson DR; Guidotti A; Costa E
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):348-53. PubMed ID: 14684836
[TBL] [Abstract][Full Text] [Related]
16. RELN-expressing neuron density in layer I of the superior temporal lobe is similar in human brains with autism and in age-matched controls.
Camacho J; Ejaz E; Ariza J; Noctor SC; Martínez-Cerdeño V
Neurosci Lett; 2014 Sep; 579():163-7. PubMed ID: 25067827
[TBL] [Abstract][Full Text] [Related]
17. GABAergic dysfunction in mGlu7 receptor-deficient mice as reflected by decreased levels of glutamic acid decarboxylase 65 and 67kDa and increased reelin proteins in the hippocampus.
Wierońska JM; Brański P; Siwek A; Dybala M; Nowak G; Pilc A
Brain Res; 2010 Jun; 1334():12-24. PubMed ID: 20353761
[TBL] [Abstract][Full Text] [Related]
18. Colocalization of integrin receptors and reelin in dendritic spine postsynaptic densities of adult nonhuman primate cortex.
Rodriguez MA; Pesold C; Liu WS; Kriho V; Guidotti A; Pappas GD; Costa E
Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3550-5. PubMed ID: 10725376
[TBL] [Abstract][Full Text] [Related]
19. REELIN and schizophrenia: a disease at the interface of the genome and the epigenome.
Costa E; Chen Y; Davis J; Dong E; Noh JS; Tremolizzo L; Veldic M; Grayson DR; Guidotti A
Mol Interv; 2002 Feb; 2(1):47-57. PubMed ID: 14993361
[TBL] [Abstract][Full Text] [Related]
20. GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon.
Guidotti A; Auta J; Davis JM; Dong E; Grayson DR; Veldic M; Zhang X; Costa E
Psychopharmacology (Berl); 2005 Jul; 180(2):191-205. PubMed ID: 15864560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
